(Q36347308)

English

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). (English)

1 reference

Europe PubMed Central

13 August 2017

phase III clinical trial

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

6

object named as

George Wilding

1 reference

Europe PubMed Central

13 August 2017

author name string

Catherine M Tangen

1

1 reference

Europe PubMed Central

13 August 2017

Maha H A Hussain

2

1 reference

Europe PubMed Central

13 August 2017

Celestia S Higano

3

1 reference

Europe PubMed Central

13 August 2017

Mario A Eisenberger

4

1 reference

Europe PubMed Central

13 August 2017

Eric J Small

5

1 reference

Europe PubMed Central

13 August 2017

Bryan J Donnelly

7

1 reference

Europe PubMed Central

13 August 2017

Paul F Schelhammer

8

1 reference

Europe PubMed Central

13 August 2017

E David Crawford

9

1 reference

Europe PubMed Central

13 August 2017

Nicholas J Vogelzang

10

1 reference

Europe PubMed Central

13 August 2017

Isaac J Powell

11

1 reference

Europe PubMed Central

13 August 2017

Ian M Thompson

12

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

22 August 2012

1 reference

Europe PubMed Central

13 August 2017

Journal of Urology

1 reference

Europe PubMed Central

13 August 2017

188

1 reference

Europe PubMed Central

13 August 2017

1164-1169

1 reference

Europe PubMed Central

13 August 2017

4

1 reference

Europe PubMed Central

13 August 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

30 September 2017

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

30 September 2017

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

30 September 2017

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

30 September 2017

Association of African-American ethnic background with survival in men with metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

30 September 2017

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

30 September 2017

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

22 September 2018

Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

22 September 2018

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481164

22 September 2018

Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853). European Organization for Research and Treatment of Cancer--Genitourinary Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22921015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter randomized trial comparing Zoladex with Zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update. International Prostate Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22921015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22921015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22921015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22921015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/22921015

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2012.06.046

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36347308&oldid=1623567256"